2. Academic Validation
  3. KT5823 activates human neutrophils and fails to inhibit cGMP-dependent protein kinase phosphorylation of vimentin

KT5823 activates human neutrophils and fails to inhibit cGMP-dependent protein kinase phosphorylation of vimentin

  • Res Commun Chem Pathol Pharmacol. 1991 Oct;74(1):3-14.
T A Wyatt 1,  K B Pryzwansky,  T M Lincoln
Affiliations

Affiliation

  • 1 Department of Pathology, University of North Carolina, Chapel Hill 27599-7525.
PMID: 1666198
Abstract

The effectiveness of the cGMP-dependent protein kinase inhibitor, KT5823, was investigated in human neutrophils. KT5823 did not inhibit the cGMP-dependent protein kinase mediated in vitro, or in situ phosphorylation of vimentin, a known substrate for this Enzyme in activated neutrophils. In addition, KT5823 was shown to induce dramatic shape changes in neutrophils, suggesting it has an activating effect upon the cells.

Figures